Devices containing active agents, for example, to prevent or contain bacterial infection through silver ions [13,14,15] or antibacterial drugs release [16,17], to enhance wound closure by exploiting conductive properties [18], or to actively stimulate the healing process using specific GFs, such as the vascular endothelial growth factor (VEGF) [19] or the basic fibroblast growth factor (bFGF) [20,21], have already been extensively studied. The gene discussed is FGF2; the disease is bacterial infectious disease.